• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to footer
Mass Tort News

Mass Tort News

News Articles for Mass Tort Attorneys

  • Facebook
  • LinkedIn
  • Twitter
  • YouTube
  • Home
  • News
  • LegalCast
  • Live Trials
  • Contact Us
Home / Current Litigation / PARAQUAT MDL 3004 UPDATE

PARAQUAT MDL 3004 UPDATE

Categories: Current Litigation Tags: current litigation, paraquatFebruary 24, 2022 by Mark York Leave a Comment

PARAQUAT PRODUCTS LIABILITY LITIGATION
Case No. 3:21-md-3004-njr 

Chief Judge Nancy Rosenstengel

US District Court, SD Illinois 

February 22, 2022

By Mark A. York 

(MASS TORT NEWS) Paraquat MDL 3004 Chief Judge Nancy Rosenstengel has scheduled the first bellwether trial to start on November 15, 2022. Subsequent trials have dates of March 13, 2023, June 12, 2023, and September 18, 2023. A second Paraquat docket is underway in California state court and  consolidated in Contra Costa County by the state’s Judicial Counsel, having been assigned California Judicial Coordination case number JCCP 5031, before Honorable Judge Edward G. Weil. 

There are now 681 (See JPML LINK) lawsuits pending in the Paraquat MDL. MDL Judge Nancy Rosenstengel issued an order requiring all Paraquat plaintiffs to complete a Plaintiff’s Assessment Questionnaire (PAQ), also known as Plaintiffs Fact Sheet. The PAQ is the prove up tracking document for discovery requests, where plaintiffs provide documents and answer questions regarding their medical and employment history and their exposure to Paraquat,(the case consolidated interrogatories and requests for production).

Court link: PARAQUAT MDL 3004 USDC SD ILLINOIS-court mdl3004.gov

June 7, 2021 MDL 3004 JPML Transfer and Consolidation Order: 

https://www.jpml.uscourts.gov/sites/jpml/files/MDL-3004-Transfer%20Order-05-21.pdf

Summary: There are certain variables that may impact the Paraquat MDL which relate to current Syngenta ownership structure (China based) as well as the political views of this becoming a Roundup II (Bayer purchase of Monsanto and assuming legal liabilities of the Roundup docket). There is an unknown yet potentially critical variable of Syngenta’s board.

 1. Do they want a quick opt-out and settlement due to the bad press and optics of owning a product that’s considered globally dangerous.

 2. Syngenta assumes a hard corporate stance and fight the litigation as is the common standard of foreign entities from Asia, this Syngenta group is an unknown yet highly financially capable entity (see link below to Syngenta Chinese Board of Directors). The number of cases filed to date versus the global pool is unknown at this point, there are claims from select “ESC” level firms that they have hundreds of cases each that are in the filing pipeline. Target number of case filed by January 1, 2022 should be at least 1000 formally filed cases in MDL 3004, to ensure that the docket is viable as to sincere settlement discussion and potentially securing a quick opt out.   

3. There is also science emerging regarding “latent pregnancy and in-utero” issues regarding potential birth defects from Paraquat exposure that may be able to support the “over-spray: claims as a very specific pool of claims, but this expanded viable science will help the overall claims valuations to show additional harmful effects. 

4. Suppression of science and medical data Paraquat as a harmful chemical agent rests on ESC/PSC ability to prove the science and having same admitted, where the popular science views are that “paraquat is dangerous” which will again directly relate back to current Syngenta ownership’s appetite on bad press, large verdicts and fighting a years long MDL battle.

Note-Phillips 66 and Chevron were dismissed Nov. 1, 2021 [see CMO No. 11] as defendants, which is potentially a good thing as it leaves Syngenta as sole defendant. 

About Syngenta:  Company is a wholly owned part of a Chinese based chemical conglomerate as part of a 2020 acquisition. This may affect determination of settlement timeline based on lack of MDL experience and current board appetite to assume potential major liabilities i.e. “avoiding a repeat of Bayer- Monsanto acquisition and assumption of Roundup liabilities. 

https://www.syngenta.com/en

Focus for settlement:  $11.1 billion in crop protection sales 

$14.3 billion

GLOBAL SALES

$11.1billion

“CROP PROTECTION SALES” 

$3.2 billion

SEED SALES

Board of Directors Are All Chinese Nationals: 

***https://www.syngentagroup.com/en/governance/board-of-directors

GAONING (FRANK) NING

Chairman of the Board
Member of the Board of Directors
Chairman of the Governance Committee

Professional background

Frank Ning was appointed Chairman of Sinochem Holdings Corporation Ltd. in April 2021. He served as Chairman of the Sinochem Group Co. Ltd. from 2015 and Chairman of China National Chemical Corporation Limited (ChemChina) from 2018.

Prior to his current post, Frank Ning was President of China Resources Enterprise Ltd., Vice Chairman and President of China Resources (Holdings) Co. Ltd., and Chairman of COFCO Corporation.

In addition to his functions in Syngenta Group, Frank Ning holds the following board memberships:

– Listed companies: Chairman of Pirelli & C. S.p.A., Chairman of Far East Horizon Ltd., Chairman of China Jinmao Holdings Group Ltd.

– Non-listed companies: Chairman of ChemChina, Chairman of Syngenta AG, Chairman of Sinochem Group Co. Ltd., Chairman of Luxi Group Co Ltd., Chairman of Sinochem Hong Kong (Group) Co. Ltd., Board Director of ADAMA Agricultural Solutions Ltd.

Frank Ning is Co-chair of the APEC Business Advisory Council (ABAC), Chairman of the APEC China Business Council, and Executive Director of the International Chamber of Commerce (ICC). He has been named one of China’s Most Influential Business Leaders by Fortune, recognized by CNBC in the Asia Business Leader Awards, and presented with the Asian Corporate Director award by Corporate Governance Asia.

Disclaimer: Numerous studies are now showing that prolonged exposure to paraquat can lead to early-onset Parkinson’s disease. Studies have found that agriculture workers who are exposed to paraquat over long periods have a significantly higher rate of early Parkinson’s. People who live near farms where paraquat is applied also showed increased rates of Parkinson’s disease, “inadvertent exposure is not recognized as a valid claim as of November 1, 2021 by MDL Leadership” there are others who are pursuing these claims, there is an extremely high risk that these claims may not survive final settlement census criteria.

Science In Support:

  • PP796 and Paraquat: the accidental swallowing of Paraquat is a whole different issue but it may have caused the deaths of thousands of people worldwide
  • Paraquat mice study on inhaling Paraquat and the loss of smell which underscores the toxicity with limited exposures

These products contain Paraquat:

  • Gramoxone
  • Ortho-Paraquat
  • Devour
  • Blanco
  • Paraquat Concentrate
  • Helmquat 3SL
  • Bonedry
  • Cyclone SL 2.0
  • Firestorm
  • Para-Shot 3.0

SUMMARY OF RELEVANT PARAQUAT INFORMATION 

Paraquat Toxicity

Paraquat is an extremely toxic chemical that is highly poisonous if ingested,  with Paraquat health risks leading 32 countries to ban the chemical completely.

How toxic is Paraquat? One eighth ounce of Paraquat, is enough to cause death 70% of the time. Over the last 12 years, a growing body of scientific research has established that normal occupational exposure to Paraquat can cause Parkinson’s Disease.

Parkinson’s Disease is a neurologic disorder in which deterioration of certain cells in the brain gradually impairs the brain’s ability to control motor functions in the body. Symptoms of Parkinson’s include impaired movement, tremors, lack of balance, and muscle stiffness.

One of the first studies recognizing a link between Paraquat and Parkinson’s Disease was published in the American Journal of Epidemiology in 2009. The study found that individuals who lived within 1600 feet of areas where Paraquat was regularly sprayed had a heightened risk of Parkinson’s Disease. The results of a more comprehensive study were published in 2011. This study concluded that there was a “strong association” between Paraquat and Parkinson’s.

These first 2 studies faced criticism over study criteria techniques and reliability because they were not “controlled” studies. In 2014, the results of 5 separate case-controlled studies were published in the Annual Review of Pharmacology and Toxicology, confirming exposure to Paraquat resulted in a greater risk of Parkinson’s Disease. This eventually prompted the EPA to announce in 2016 that it was conducting its own safety review of Paraquat.

On March 24, 2021, Greenpeace published “The Paraquat Papers.” This piece details the history of attempts by Syngenta and its predecessor, Imperial Chemical Industries (ICI), to conceal Gramoxone’s risks from the public. Allegedly, ICI claimed to have added the emetic PP796 in Paraquat products to prevent fatal poisoning.

Despite this claim, internal company documents revealed that it failed to do this. It also revealed that the company knew of this problem. ICI continued to publicly assert the emetic’s effectiveness. Additional documents suggest that it mischaracterized the addition of PP796 to keep Gramoxone on the market.

Jon Heylings, a former Syngenta toxicologist, also reported on the low PP796 levels in Gramoxone. He warned that the emetic levels were not enough to induce vomiting in individuals that swallowed the “minimal lethal dose.”

Heylings claimed that a former toxicologist for Imperial Chemical Industries (ICI), Syngenta’s predecessors, manipulated data to incorrectly suggest that humans were ten times as sensitive to PP796 than the other three animals that researchers used in tests. These concerns were reported in several memos where Heylings argued that the former toxicologist’s data “misled” the business, advising that higher PP796 doses would reduce the paraquat poisoning fatality rate.

Nonetheless, ICI ignored Heylings’ concerns. The PP796 levels in Gramoxone became the United Nations’ Food and Agricultural Organization’s standard for paraquat-based weed killers. Heylings will be offering deposition testimony in the Paraquat MDL litigation in 2022 sometime. 

What Is Paraquat?

Paraquat (paraquat dichloride) is an extremely toxic chemical that is used to kill weeds, grass, and other unwanted vegetation. Despite being banned in many countries, Paraquat is one of the most widely used industrial herbicides in the world.

Paraquat is legal in the U.S., but the Environmental Protection Agency (EPA), classifies it as a “restricted use” chemical. This means that Paraquat can only be bought and used by commercially licensed users, primarily. 

The Paraquat herbicide has been around since the early 1960s. The use of Paraquat has rapidly increased over the last 20 years because weeds have become resistant to other products. According to the EPA, Paraquat is currently the most commonly used type of restricted use herbicide in the U.S. Paraquat comes in liquid form and is sprayed onto crops in a variety of ways. Paraquat has a bright blue color and a distinctive odor.

Paraquat herbicides are manufactured and sold under several different brand or product trade names. Gramoxone is the most common trade name for Paraquat. Gramoxone is manufactured by Sygenta, a global agrochemical company now owned by a Chinese chemical consortium.

Disclaimer: Numerous studies are now showing that prolonged exposure to paraquat can lead to early-onset Parkinson’s disease. Studies have found that agriculture workers who are exposed to paraquat over long periods have a significantly higher rate of early Parkinson’s. People who live near farms where paraquat is applied also showed increased rates of Parkinson’s disease, however “inadvertent exposure” may not be recognized as a valid claim.

Paraquat Lawsuit History

The link between Paraquat and Parkinson’s Disease has been known to manufacturers for years, but never publicly disclosed

The first Paraquat Parkinson’s disease Paraquat lawsuit was filed in Missouri in 2017 against Syngenta, the Swiss-headquartered, Chinese-owned agrochemical company that now makes the drug, and Growmark (another company that makes Paraquat products).

The plaintiffs were farm owners and agricultural laborers who either applied Paraquat or worked on farms where Paraquat was used and later developed Parkinson’s Disease. 

One million Americans have Parkinson’s disease, depending on the percentage of links to Paraquat use will determine the docket size. Given the severity of Parkinson’s disease and how the science is presented, this has the potential to be a significant MDL.

Comparatives for paraquat cases in which Parkinson’s disease was the plaintiff’s primary injury.

Parkinson’s is not a common injury in personal injury claims. Because Parkinson’s is such an uncommon injury in tort cases, we can look at settlements cases filed involving  for tardive dyskinesia, a condition that is similar to Parkinson’s.

  • Tamaraz v Lincoln Electric (Ohio 2007) $20,500,000 Verdict: this was a welding rod product liability case in which the plaintiff alleged that he developed Parkinson’s disease from exposure to manganese in welding rods. Jury awarded $17.5 million to him and another $3 million to his wife. This was the only welding rod case that ended in a verdict for the plaintiff.
  • Axe v Spring Meadows (Pennsylvania 2018) $215,000 Settlement: Plaintiff was 73 and alleged that he developed tardive dyskinesia from medications given to him by a nursing home. Settlement value of this case was low because the plaintiff was older.
  • Plaintiff v Defendant (New York 2017) $1,400,000 Settlement: Plaintiff (mid-30s) develops tardive dyskinesia from antipsychotic medication used to treat her bi-polar and sues doctor who prescribed it.
  • Soref v Agresti (Florida 2017) $569,000 Verdict: female in her mid-20s with history of drug abuse claims bi-polar drugs cause her to develop tardive dyskinesia.

Multidistrict Litigation PARAQUAT PRODUCTS LIABILITY LITIGATION Case No. 3:21-md-3004-njr

Judge Nancy Rosenstengel US District Court Southern District Illinois, 


PARAQUAT PRODUCTS LIABILITY LITIGATION
Case No. 3:21-md-3004-njr Chief Judge Nancy Rosenstengel

Court link: PARAQUAT MDL 3004 USDC SD ILLINOIS-court mdl3004.gov

Docket Report (PACER)

Paraquat MDL Discovery Portal

Plaintiff’s Assesment Questionnaire (PAQ)

PAQ Authorizations

Paraquat MDL Portal User Guide

The 2 critical orders are regarding Common Benefit Fund designations (assessment amount to be determined “up to 12%” of gross recovery fees):

10-13-202110-13-2021Order No. 9 – Establishment of Common Benefit Fee and Expense Fund
10-13-202110-13-2021Order No. 9 – Exhibit A Common Benefit Participation Agreement

Recent relevant orders through February 14, 2022


1234
Date PostedDate SignedDescription
2-14-20222-14-2022Order Granting in Part and Denying in Part Defendant’s Motion to Dismiss
2-08-20222-08-2022Order Directing Defendants to Produce Transcripts of Corporate Witness Depositions
1-18-20221-18-2022Order Adopting Special Master’s Report and Recommendations Regarding CMO No. 7
1-18-20221-18-2022Exhibit 1: Plaintiff’s Fact Sheet (PFS)
1-18-20221-18-2022Exhibit 2: PFS Authorizations
1-07-20221-07-2022Order Identifying Early Trial Selection Cases
12-15-202112-15-2021Order No. 13 – Regarding Rule 502(d) and Privileged Materials
12-06-202112-06-2021Order Adopting Special Master’s Report and Recommendations Regarding CMO No. 12
12-03-202112-03-2021Order No. 12 – Protocol for the Selection of Trial Cases

Useful Court Links:

Lead Counsel and Plaintiffs’ Executive Committee

Minutes of Proceedings

New Case Filing Instructions

Special Master

Upcoming Court Proceedings

Upcoming Deadlines

Prior relevant orders of note

[October 1, 2021 Update] Despite calls to ban Paraquat in the U.S., in July the EPA re-approved the controversial herbicide for use by licensed farmers. In September 2021, public interest groups filed a petition in the 9th Circuit Court of Appeals seeking to overturn the EPA’s decision, seeking to ban Paraquat in the U.S.

[August 19, 2021 Update] USDC SD Illinois Chief Judge Nancy Rosenstengel held an initial case management conference, outlining a schedule that will set the docket timeline through trials, with the first bellwether trial set for November 2022.

[July 14, 2021 Update] Case Management Order, designating Randi S. Ellis as the MDL special master, to set a schedule for motions and discovery, establishing discovery protocols, a plaintiffs’ database and selecting plaintiffs’ claims for trial.

For further information on this article or other media publications please contact:

Mark York

Editor 

Mass Tort News

LegalCast

[email protected]

Mark York
Mark York
masstortnews.org/
Share on Facebook Share
Share on TwitterTweet
Share on LinkedIn Share
Send email Mail

Categories: Current Litigation Tags: current litigation, paraquat

Reader Interactions

Leave a Reply Cancel reply

You must be logged in to post a comment.

Primary Sidebar

Search

E-mail Newsletter

Sign up to receive weekly updates on the latest in Mass Tort News.

Recent Episodes

John K. Rabiej served as the Deputy Director of the Bolch Judicial Institute for one year, and as the Director of the Duke Law Center for Judicial Studies for seven years. The Duke Law Center brings together judges, lawyers, researchers, government officials and other parties to advance the study and understanding of the judicial process and generate ideas for how it might be improved. During his time as the Director of the Duke Law Center, Mr. Rabiej studied the impact of technology on the judiciary, including analyzing his concerns that the courts are not keeping pace with the rapid advancement of technology in the culture at large. Prior to joining the Duke Law Center, Mr. Rabiej served as the Executive Director and Director of Judicial Outreach for The Sedona Conference; the Chief of the Rules Committee Support Office; and the American Law Institute. He presently sits on the Chief Justice’s Rules Advisory Commission, North Carolina (term ending December 31, 2023). In this episode of LegalCast, Mr. Rabiej discusses a legal bipartisan review of mass torts, class action, and the ever-expanding e-discovery quagmire that seems to be firmly embedded in complex litigation coming to a peak in 2022.  Will the plaintiffs and defense leadership be able to collaborate to reign in the ever-expanding high cost of litigation? Mr. Rabiej has made a career of working to bring opposing groups together to discuss common interests as a means to increase efficiencies in litigations. And, with millions of dollars at stake, why not at least start the discussions.

Remember to subscribe and follow us on social media…

LinkedIn: https://www.linkedin.com/company/mass-tort-news
Twitter: https://www.twitter.com/masstortnewsorg
Facebook: https://www.facebook.com/masstortnews.org
Is Judicial Review On The Horizon?
YouTube Video VVVuSC1KSll3UzVNWHQwMEgyUndoR3Z3LmlkM1ZiUVJMYkdZ
Stephen P New. of Beckley West Virginia is one of the country’s leading opioid litigators, by bringing the fight directly to Opioid Big Pharma's doorstep. Steve and the Opioid Justice Team have been defending and advocating for the rights of the neonatal abstinence syndrome afflicted infants, aka the "NAS Babies." Who are the truly innocent victims of the now decades-old opiate crisis in America.

Remember to subscribe and follow us on social media…

LinkedIn: https://www.linkedin.com/company/mass-tort-news
Twitter: https://www.twitter.com/masstortnewsorg
Facebook: https://www.facebook.com/masstortnews.org
Leading the Fight for Opioid Addicted Infants
YouTube Video VVVuSC1KSll3UzVNWHQwMEgyUndoR3Z3LnhNbHdDSGU3ZzZZ
George Haj is a Pulitzer-Prize winning editor who founded Haj Media in 2017. Haj Media is a strategic communications firm focusing on crisis communications, media relations, and litigation support for law firms and corporate clients. Prior to launching his own consulting firm, George spent three decades working in some of the nation’s largest news organizations. He has deep roots in the media industry and connections with reporters and editors in a range of publications across the country. George worked as executive business editor at the Miami Herald and then was a top editor at the Houston Chronicle. He also served as editorial director of ALM Media, where he directed a global newsroom of more than 100 journalists and oversaw iconic brands including The American Lawyer and National Law Journal. He can be reached at george@hajmedia.com. Find him on Twitter: https://twitter.com/georgehaj, LinkedIn: https://www.linkedin.com/in/george-haj-25ba481, and at http://www.hajmedia.com/. 

Remember to subscribe and follow us on social media…

LinkedIn: https://www.linkedin.com/company/mass-tort-news
Twitter: https://www.twitter.com/masstortnewsorg
Facebook: https://www.facebook.com/masstortnews.org
Crisis Management & Media Training for Lawyers
YouTube Video VVVuSC1KSll3UzVNWHQwMEgyUndoR3Z3LmhvVDk2Q2MxUnpR
With four decades of experience in legal advertising with a passion for legal marketing, intake, and conversion, Harlan Schillinger has more than earned his title as the Grandfather of Legal Advertising. 

Harlan was the first in the industry to produce and market TV advertising for the legal community. In 1975, along with his partners, Harlan founded the first syndication TV production firm for high-end retailers and Lawyers, creating television commercials that aired throughout North America.

Since the late 1970s, Harlan has worked aggressively, productively, and professionally within the legal advertising space. He has said that: “Creating opportunities and increasing market share for advertising law firms is [his] #1 priority. The value of the case is everything in such a crowded market.” Harlan privately consults with lawyers who not only share his values, but who also share his vision of increasing business, being accountable, and obtaining high-value cases. His approach to intake and conversion rests on complete accountability within that area and he is known to practice what he preaches. Harlan has trademarked within the legal advertising world the two phrases that have become his backbone of philosophy: What You Don't Know, You Don't Know® and Ambassador of First Impressions™.

Since that time, Harlan has worked with more than 130 law firms in almost 100 markets throughout North America. Before joining Network Affiliates in 1985, Harlan was a founding partner and VP of Madison, Muyskens & Jones, a Connecticut-based advertising agency. In April 2016 Harlan retired from Colorado-based Network Affiliates, the nation's first and largest full-service legal advertising agency, where he was the leader of their attorney marketing efforts for over 34 years.

A few years ago, Harlan and two of his partners – Dino Colombo Esq. and Eric Coffman – developed Lead Docket, software for intake and conversion within law firms. Harlan says that Lead Docket helps law firms increase control and management of intake and conversion, allowing the firms to thrive.

Harlan is involved with a number of professional organizations, being a member of the National Trial Lawyers Executive Summit Committee as well as a Senior Editor and Writer for the National Trial Lawyers Magazine. He also has a passion for riding and building custom motorcycles, and is a proud member of the most prestigious motorcycle group in the world: Hamsters USA ® Motorcycle Group.

Learn more about Harlan at http://www.harlanschillinger.com/. 
And to check out the book he recommends – How to Win Friends & Influence People by Dale Carnegie and originally published in 1936 click here: https://www.amazon.com/How-Win-Friends-Influence-People/dp/0671027034. 

Remember to subscribe and follow us on social media…

LinkedIn: https://www.linkedin.com/company/mass-tort-news
Twitter: https://www.twitter.com/masstortnewsorg
Facebook: https://www.facebook.com/masstortnews.org
Prep Like a Pro: Legal Networking Tips & Tricks
YouTube Video VVVuSC1KSll3UzVNWHQwMEgyUndoR3Z3LjJJRW9MWUh1UkZ3
Christos Lagos has been the co-managing partner of Lagos & Priovolos PLLC since 2014 when he and John Priovolos formed the firm. Christos, who has over 23 years of legal experience, heads the firm's civil litigation division. His primary focus is on claims that involve substantial losses arising out of construction negligence, unsafe premises, automobile and trucking accidents, medical malpractice, wrongful death, negligence, defective products, insurance claims, and other civil disputes. 
 
Christos is a seasoned and accomplished trial lawyer with an exceptional track record of success handling high-profile litigation. His experience as lead counsel in numerous jury trials has proven invaluable in the guidance and expertise he offers his clients. He has obtained several multi-million dollar settlements, judgments, and jury verdicts and is a standing member of both the Million Dollar Advocates Forum and the Multi-Million Dollar Advocates Forum. In total, Christos has helped recover over $150 Million for those whose lives have been harmed by the wrongdoing of others. 
 
Over the last 20 years, Christos has successfully litigated against insurance companies, construction and engineering firms, major consumer product and automobile manufacturers, property owners, health care providers, trucking and transportation companies, and other entities and corporations. Christos holds a Certificate in Mass-Tort Multidistrict Litigation (MDL) from the Bolch Judicial Institute at Duke Law School. Throughout his career, Christos has handled several notable landmark cases. Notably, Christos filed the first wrongful death lawsuit for the tragic bridge collapse that occurred at Florida International University. Twenty personal injury and wrongful death cases were consolidated against twenty-eight defendants involving over 100 lawyers.  Christos served as Liaison Counsel and was a lead attorney in this consolidated action. On behalf of all plaintiffs' counsel, Christos conducted numerous presentations and led global settlement negotiations resulting in the creation of a trust for the benefit of the bridge collapse victims in the amount of $102.75 Million from twenty-five defendants. 
 
Judge Jennifer D. Bailey, Administrative Judge of the Eleventh Judicial Circuit in Miami-Dade County, who presided over the FIU bridge collapse litigation, had this to say about him: 
 
"Everyone should be extraordinarily grateful for Mr. Lagos's service as the lead court liaison. A significant portion of why this case has moved as efficiently as it has is because he stepped up to do this."

 - Honorable Judge Jennifer D. Bailey
Administrative Judge, Circuit Civil Division
Eleventh Judicial Circuit of Florida in and for Miami-Dade County

To view news clips and statements from Judge Bailey and other counsel involved in the FIU bridge collapse litigation, click here: https://vimeo.com/694264408/f5251ce891 . 
 
Read more about Christos here: http://www.lpesq.com/ . And connect with him on LinkedIn here: https://www.linkedin.com/in/christoslagos/ . 

Remember to subscribe and follow us on social media…

LinkedIn: https://www.linkedin.com/company/mass-tort-news
Twitter: https://www.twitter.com/masstortnewsorg
Facebook: https://www.facebook.com/masstortnews.org
Mass Tort Tragedy: the FIU Bridge Collapse with Christos Lagos
YouTube Video VVVuSC1KSll3UzVNWHQwMEgyUndoR3Z3LkFJWVoycXk2SE5V
Vicki J. Maniatis is a partner at Milberg Coleman Bryson Phillips Grossman who has worked on mass tort cases involving pharmaceuticals and medical devices for seventeen years. She is a frequent invited lecturer and moderator on a wide variety of pharmaceutical and mass tort cases including, Opioids, Trans Vaginal Mesh, Fosamax, Ortho Evra, Risperdal, Propecia, Avandia, Onglyza, as well as several medical devices. Vicki has been appointed by State and Federal Judges to serve as lead counsel and on Plaintiffs’ steering committees. She has significant experience performing all levels of bellwether trial case-specific work up including, plaintiff, spouse and family member depositions, implanting, explanting, treating physicians, sales representative, and expert depositions, for over 30 cases in several mass torts including TVM, Mirena and Propecia cases.

Vicki serves as a founding member of Mass Tort Med School, an annual medical seminar for Plaintiffs’ attorneys that offers numerous physician speakers and cutting-edge medical issues. In May 2022, along with the Trial Lawyers of Puerto Rico, Mass Tort Med School is hosting Mass Torts Puerto Rico, a first-of-its-kind program where attorneys will have the opportunity to learn from and connect with world-class trial lawyers and experts – the Mass Tort Med School program will be bigger and better than ever.

Remember to subscribe and follow us on social media…

LinkedIn: https://www.linkedin.com/company/mass-tort-news
Twitter: https://www.twitter.com/masstortnewsorg
Facebook: https://www.facebook.com/masstortnews.org
The Expert Whisperer with Vicki Maniatis
YouTube Video VVVuSC1KSll3UzVNWHQwMEgyUndoR3Z3Lk9UQWlzZUhSVllz
Pedram Esfandiary is an attorney in the Los Angeles office of Baum Hedlund Aristei & Goldman, where he concentrates his practice on toxic tort injuries, pharmaceutical drug liability, class actions, consumer fraud litigation and police misconduct lawsuits.

He currently leads the firm’s legal team that is filing lawsuits against manufacturers of baby food for knowingly selling baby food with with “dangerously high levels” of toxic heavy metals. This new mass tort litigation involves allegations against the major brand manufacturers (Nurture Happy Family Organics, Beech-But, Hain, Plum Organics, Walmart-Parent’s Choice, Sprout Foods and Gerber) that their baby food contains dangerous levels of arsenic, cadmium, lead and mercury, which are all considered toxic heavy metals and are known to damage neurological development and brain development in infants and are associated with autism and ADHD in children.

Pedram was an integral part of the trial team that won the historic $2 billion verdict against Monsanto (now Bayer) in May 2019 on behalf of a couple who together sprayed Roundup weed killer on their properties for 30 years. The jury awarded Alva and Alberta Pilliod $55 million in compensatory damages. Pedram was also served in a similar capacity on the very first Roundup cancer case to go to trial against Monsanto, resulting in a $289 million verdict on behalf of groundskeeper Dewayne “Lee” Johnson. And he participated in the second Roundup trial against Monsanto on behalf of Edwin Hardeman. The jury in that trial awarded Mr. Hardeman $80 million for his damages.

A winner on Law360’s Rising Stars Top 40 Under 40 list for 2019, Pedram has been recognized as an attorney whose legal accomplishments transcends his age. He has also been selected to Southern California Super Lawyers® – Rising Stars and the National Trial Lawyers Top 40 Under 40.
Read Pedram’s full bio on the Baum Hedlund website here.

Remember to subscribe and follow us on social media…

LinkedIn: https://www.linkedin.com/company/mass-tort-news
Twitter: https://www.twitter.com/masstortnewsorg
Facebook: https://www.facebook.com/masstortnews.org
Toxic Heavy Metals in Baby Food with Pedram Esfandiary
YouTube Video VVVuSC1KSll3UzVNWHQwMEgyUndoR3Z3LnRUQU5GZTh0OGpr
LegalCast spent a few minutes with 1st-year law student, Bailey Webster, at the 4th Annual Class Action Law Forum, at her school, Univ of San Diego. Bailey is very dynamic, engaging as well as being forward-thinking 8n how she sees herself as both a student, but also an up-and-coming legal professional. 

Watch and listen as one of America's emerging lawyers states clearly, how and why she chose law as a career and how she's shaping her own future.  

Bailey is definitely a young lawyer to keep an eye on in the future, "that's for all you recruiters at the tier one firms." 

Kudos to the USD School of Law class of 2024 for attracting students like Bailey.

Remember to subscribe and follow us on social media…

LinkedIn: https://www.linkedin.com/company/mass-tort-news
Twitter: https://www.twitter.com/masstortnewsorg
Facebook: https://www.facebook.com/masstortnews.org

http://www.westernalliancebancorporation.com/
Minute with Mark - Decisions, Decisions: Class action, commercial lit, intellectual property?
YouTube Video VVVuSC1KSll3UzVNWHQwMEgyUndoR3Z3LjJuYXlJYVdXZEZj
Hello America's law firms, meet Arif Salam, the type of up-and-coming lawyer in a 1st-year law student, who you want to get on your firm's radar. 

Arif has chosen class action law as his practice area of choice, already making inroads and connections by interacting with senior Class Action lawyers at the 4th annual class action law forum hosted by the University of San Diego school of law, where Arif is a first-year student.

Motivated and confident enough to interact with lead class action counsel from across the country and very capable of holding his own in a discussion that not many 1st years are given the opportunity to engage in. A legal mover in the making 'Arif Salam." 

Remember to subscribe and follow us on social media…

LinkedIn: https://www.linkedin.com/company/mass-tort-news
Twitter: https://www.twitter.com/masstortnewsorg
Facebook: https://www.facebook.com/masstortnews.org

http://www.westernalliancebancorporation.com/
Minute with Mark - 1st year at Univ of SD School of Law? Is class action law for me?
YouTube Video VVVuSC1KSll3UzVNWHQwMEgyUndoR3Z3LjN2NVh3TS1Mci1v
Jason Velez is a partner at the Cochran Firm in its Salt Lake City and St. George offices in Utah. He is also the Founder and CEO of 1Law https://www.1law.com, a company that leverages artificial intelligence to make lawyers more efficient and lower costs for consumers. By doing so, 1Law helps drive new business to attorneys, which in turn improves the user experience for consumers.  
 
1Law utilizes artificial intelligence to augment, rather than replace lawyers’ ability to provide top-notch legal services to their clients. The 1Law platform allows lawyers and clients to communicate, share information, and access information on a real-time basis, from anywhere. Built on cutting-edge technology, 1Law helps improve access to justice by making quality legal representation available to all through the profitability of personal injury law. 
 
Connect with Jason on LinkedIn here.

Remember to subscribe and follow us on social media…

LinkedIn: https://www.linkedin.com/company/mass-tort-news
Twitter: https://www.twitter.com/masstortnewsorg
Facebook: https://www.facebook.com/masstortnews.org
THE VALUE OF LEGAL TECHNOLOGY with Jason Velez
YouTube Video VVVuSC1KSll3UzVNWHQwMEgyUndoR3Z3LlZIMjRHMEFIcUNj
Load More... Subscribe

Popular Tags

current litigationopioid crisisconsumer protectioncovid-19emerging tortszantacpurdue pharmaeventsackler familyjuul

Footer

Search

Main Navigation

  • Home
  • News
  • LegalCast
  • Live Trials
  • Contact Us

Categories

Events

Trial Lawyers Summit 2022

February 16, 2022 By Mass Tort News

2021 Trial Lawyers Summit Recap

May 11, 2021 By Mark York

2021 TRIAL LAWYERS SUMMIT

May 4, 2021 By Mass Tort News

More Posts from this Category

MASS TORT NEWS

Latest Mass Tort Litigation News

  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

Copyright © 2022 · Mass Tort News · All Rights Reserved.